Whalesbook
Record Revenue and Secured Orders
Building on its record annual revenue, TANFAC Industries is securing its future with substantial new orders. The company has locked in contracts totaling INR 1,068 crore for solar-grade Difluoromethane (DHF) over 3.5 years and INR 3,612 crore for various fluorinated products over 5 to 7 years. A key strategic move driving future growth is the ongoing INR 495 crore capital expenditure project for Hydrofluorocarbon-32 (HFC-32) and other value-added products, expected to be commissioned by the third quarter of FY27.
Strategic Shift to Specialty Chemicals
This marks TANFAC's transition towards becoming a significant player in high-value specialty fluorochemicals. Being India's sole manufacturer of solar-grade DHF gives it a distinct advantage in growing markets like photovoltaics and semiconductors. These aggressive expansion plans, especially for HFC-32, are designed to nearly triple current revenues. TANFAC projects reaching INR 2,000 crore by FY28, with a long-term aim of INR 3,000–3,500 crore within five years. The HFC-32 project is expected to deliver a payback in under four years.
Company Background
TANFAC Industries joined the Aditya Birla Group in 2023, a significant step for both entities. This acquisition bolsters TANFAC's access to resources and markets, supporting its expansion in the specialty chemicals sector. The INR 148 crore revenue from FY21 highlights the substantial scale-up now underway.
Key Developments
- TANFAC is solidifying its position in niche, high-growth specialty chemical markets.
- The company is set to become a major domestic supplier for HFC-32, a key refrigerant.
- Significant order backlogs provide revenue visibility for the medium term.
- The planned capacity expansions are expected to drive substantial revenue growth.
Potential Risks
- An unplanned bottleneck in the older HF-1 plant led to a production loss of INR 70 crore in FY26.
- Currency fluctuations, particularly the depreciation of the Indian Rupee, resulted in a valuation loss of INR 2.5–3 crore in Q4 FY26.
- Regulatory uncertainty remains as the government has not finalized HFC production quota allocations. Quotas are set to be frozen and allocated from 2028.
Competitive Landscape
TANFAC competes with established players like Gujarat Fluorochemicals Ltd., Navin Fluorine International Ltd., and SRF Ltd. While Gujarat Fluorochemicals is expanding fluoropolymer capacity and Navin Fluorine focuses on contract research and manufacturing services (CRAMS), TANFAC stands out with its unique position as the sole producer of solar-grade DHF and its strategic HFC-32 expansion.
Key Financial Targets
- Expected EBITDA margins for existing businesses are projected to remain in the range of 15% to 18% for FY27.
- The company has set an ambitious revenue target of INR 2,000 crore by FY28.
- Long-term revenue aspirations aim for INR 3,000–3,500 crore within the next five years.
What to Watch Next
- Finalization of government policies regarding HFC production quota allocations.
- Progress and timely commissioning of the INR 495 crore HFC-32 project.
- Management's ability to secure a high percentage of contracted capacity before plant operationalization.
- Announcement of the planned new 30,000-ton Anhydrous Hydrofluoric Acid (AHF) plant expansion.
- Trends in key input costs, such as sulphur prices, and their pass-through effectiveness.
- Performance of TANFAC against its ambitious revenue targets for FY28 and beyond.